Biohit Oyj (HEL:BIOBV)

Finland flag Finland · Delayed Price · Currency is EUR
2.660
-0.010 (-0.37%)
Apr 28, 2026, 5:38 PM EET
2.58%
Market Cap 40.45M
Revenue (ttm) 15.73M
Net Income (ttm) 2.74M
Shares Out 15.21M
EPS (ttm) 0.18
PE Ratio 14.78
Forward PE 17.73
Dividend n/a
Ex-Dividend Date n/a
Volume 5,931
Average Volume 9,874
Open 2.720
Previous Close 2.670
Day's Range 2.610 - 2.790
52-Week Range 2.200 - 3.780
Beta 0.50
RSI 67.16
Earnings Date Aug 5, 2026

About Biohit Oyj

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1988
Employees 46
Stock Exchange Nasdaq Helsinki
Ticker Symbol BIOBV
Full Company Profile

Financial Performance

In 2025, Biohit Oyj's revenue was 15.73 million, an increase of 10.14% compared to the previous year's 14.28 million. Earnings were 2.74 million, an increase of 6.62%.

Financial Statements

News

There is no news available yet.